Addus HomeCare (ADUS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Fourth quarter 2025 revenue reached $373.1 million, up 25.6% year-over-year, with full-year revenue at $1.42 billion, a 23.2% increase from 2024.
Adjusted EPS for Q4 was $1.77, up 28.3% year-over-year; full-year adjusted EPS was $6.23, up 18.4%.
Adjusted EBITDA for Q4 was $50.3 million, up 33.3% year-over-year; full-year adjusted EBITDA was $180 million, up 28.3%.
Personal Care segment drove growth, accounting for 76.6% of Q4 revenues, with 6.3% organic revenue growth.
Three acquisitions completed in 2025, including Del Cielo Home Care Services, expanding market reach.
Financial highlights
Q4 gross margin was 33.1%, down from 34.2% in Q4 2024, mainly due to a higher mix of Personal Care Services.
G&A expense was 20.7% of revenue, down from 24% in Q4 2024; adjusted G&A was 19.1%, down from 20.5%.
Net cash flow from operations was $18.8 million for Q4 and $111.5 million for 2025.
Cash on hand at year-end was $81.6 million; bank debt was $124.3 million, with $517.7 million available under the credit facility.
Operating income for Q4 2025 was $42.3 million, up from $26.9 million in Q4 2024.
Outlook and guidance
Q1 2026 expected to benefit from Illinois rate increase, offset by two fewer business days and seasonal winter storm impacts.
Gross margin % expected to decline sequentially by about 120 basis points in Q1 2026 due to annual merit increases and payroll tax resets.
Management expects continued growth through organic expansion and acquisitions in 2026.
Recent state rate increases in Texas (9.9%) and Illinois (3.9%) are expected to positively impact future revenues.
Continued focus on disciplined capital allocation and ongoing debt reduction while pursuing strategic acquisitions.
Latest events from Addus HomeCare
- Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Growth driven by acquisitions, tech, and value-based care, with census recovery expected by 2026.ADUS
Jefferies 2025 Healthcare Services Conference3 Feb 2026 - Q2 revenue up 10.4%, net income $18.1M, major equity raise, Gentiva deal, NY divestiture.ADUS
Q2 20242 Feb 2026 - Strong growth, strategic market exits, and value-based care drive expansion and resilience.ADUS
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q3 revenue up 7%, EPS up 13%, with Gentiva deal and NY exit to drive future growth.ADUS
Q3 202416 Jan 2026 - Personal care expansion, M&A, and tech integration drive growth; margins seen at 11-12%.ADUS
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Strong growth, smooth integration, and favorable labor trends set up a robust 2025.ADUS
KeyBanc Annual Healthcare Forum 202526 Dec 2025